Table 1.

Post-Treatment Change of Subjective Measures

Parameter	All (n = 34)			Cervical (n = 23)			Thoracic (n = 11)
	Pre	Post	p	Pre	Post	p	Pre	Post	p and (Z, r)
24-h ABPM
Total AD episodes	10 [6–21]	8 [4–13]	0.03	11 [8–22]	9 [6–16]	0.2	7 [5–15]	3 [1–7]	0.06 (−2, −0.6)
Bladder-related AD episodes	4.5 [2–8.8]	2 [1–4.8]	0.01	6 [1.5–10]	3 [1–5.5]	0.09	4 [2–6]	1 [0–2]	0.04 (−2, −0.6)
AD Symptoms
Frequency score	10 [8–13]	6 [3–9.8]	<0.001	11 [8.5–13]	6 [3–9.5]	0.003	8 [5.5–13.5]	6 [3–9.5]	0.1 (−2, −0.6)
Severity score	7.5 [4.5–9]	4 [2–7.8]	<0.001	8 [6–9.5]	4 [2–7.5]	0.002	7 [3–11.5]	5 [1–7.5]	0.05 (−2, −0.6)
I-QoL
Avoidance	56 [44–71]	78 [67–84]	<0.001	59 [46–70]	81 [69–84]	<0.001	56 [42–72]	75 [58–88]	0.006 (3, 0.9)
Psychosocial Impact	54 [32–82]	83 [65–96]	<0.001	44 [34–80]	83 [69–97]	<0.001	64 [38–86]	81 [54–92]	0.06 (2, 0.6)
Social embarrassment	42 [18–68]	72 [40–90]	<0.001	40 [12–58]	80 [35–90]	<0.001	45 [25–70]	65 [40–88]	0.004 (3, 0.9)
Total	50 [36–72]	78 [63–91]	<0.001	42 [39–72]	81 [63–91]	<0.001	58 [40–74]	73 [56–88]	0.01 (3, 0.9)

24-h ABPM, 24-hour ambulatory blood pressure monitoring; AD, autonomic dysreflexia; I-QoL, incontinence quality of life; r Pearson correlation coefficient; Z, Z-score.

Data are presented as medians with interquartile ranges (25%- 5% IQR).